In glioblastoma, DDX5 has been observed to bind the N-terminus of the NF-κB p50 subunit, increasing the transcriptional activity of the p50 target genes and stimulating the growth of glioma cells [80]. This evidence concerns the gene DDX5 and central nervous system cancer.